Anette Løken Eilertsen

Author

Also Known As

A. L. Eilertsen, A.L. EILERTSEN, A.L. Eilertsen, Anette L Eilertsen, Anette L. Eilertsen, Anette Løken Eilertsen, Magnus Moksnes, Sigurd Liestøl

Publications

283

Citations

H-Index

Concepts

All Affiliations

Oslo University Hospital University of Oslo

About

Anette Løken Eilertsen is an author at Oslo University Hospital specializing in medicine, endocrinology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	233
2	Endocrinology	6	6	173
3	Obstetrics	4	4	114
4	Public Health	1	1	13
5	Epidemiology	1	1	13

Anette Løken Eilertsen

Publications

233

Citations

H-Index

Page 1

	Year	Citations
The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis Anette Løken Eilertsen, Else Høibraaten, Ingrid Os, Maturitas InflammationThrombosisThrombopoiesisCardiovascular DiseaseBlood Platelet	2005	60
Mechanisms of thrombosis related to hormone therapy Per Morten Sandset, Else Høibraaten, Anette Løken Eilertsen, Thrombosis Research ThrombopoiesisThrombosisBlood PlateletMedicineHematology	2009	55
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis Anette Løken Eilertsen, Leiv Sandvik, Marie Christine Mowinckel, Thrombosis Research ThrombosisDifferential EffectsMedicineHemostasisFibrinolysis	2006	33
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation Anette Løken Eilertsen, Elisabeth Qvigstad, Trine Opstad Andersen, Maturitas ThrombosisBlood PlateletMedicineIncrease MarkersActivated Coagulation	2006	31
Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers Anette Løken Eilertsen, Leiv Sandvik, B. STEINSVIK, Journal of Thrombosis and Haemostasis InflammationRheumatologyDifferential ImpactAnti-inflammatoryPharmacology	2008	29
Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy Trine B. Opstad, Anette Løken Eilertsen, Else Høibraaten, Blood Coagulation & Fibrinolysis Hormonal ContraceptiveGenetic EpidemiologyHuman PolymorphismGynecologyMenopausal Hormone Therapy	2010	13
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women Anders Erik Astrup Dahm, Anette Løken Eilertsen, Jelle J. Goeman, Thrombosis Research Endocrine MechanismGeneticsMicroarray StudyGynecologyMenopausal Hormone Therapy	2012	12

Page 1